Arcosa, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-71.4% vs price
Base Case (Median)
-24.3% vs price
Bull Case (75th pct.)
4.2% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $27.57 | -81.0% | High (40%) |
| PE Comparable | $193.09 | 33.2% | Medium (25%) |
| Growth Trajectory DCF | $184.97 | 27.6% | Medium (20%) |
| Graham Number | $109.74 | -24.3% | High (80%) |
| EV/EBITDA | $117.20 | -19.2% | Medium (20%) |
| EV/FCF | $55.30 | -61.9% | Medium (20%) |
| Earnings Power Value | $22.97 | -84.2% | High (70%) |
Based on 7 out of 8 methods, ACA appears fairly valued at the current price of $145.01. The base case fair value of $109.74 implies 24.3% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.